News Releases
Jan 24 2005
Peregrine Gains Access to Merck KGaA's Protein Expression Technology
Jan 21 2005
Peregrine and New Approaches to Brain Tumor Therapy (NABTT) Consortium Receive Approval for Cotara(R) Brain Cancer Protocol
Dec 10 2004
Peregrine Announces Second Quarter Financial Results
Nov 9 2004
Peregrine Pharmaceuticals and New Approaches to Brain Tumor Therapy (NABTT) Consortium Enter Collaboration to Treat Brain Cancer Patients
Nov 8 2004
Tarvacin(TM) Equivalent Plus Radiation Therapy Reduces Tumor Growth by 98%
Nov 8 2004
Peregrine Pharmaceuticals and Affitech AS Expand Collaboration to Develop Up to Six New Fully Human Antibodies
Oct 25 2004
Peregrine Pharmaceuticals Provides Tarvacin(TM) IND Update
Oct 22 2004
Review of Peregrine's Phase I Cotara(R) Clinical Data for Colorectal Cancer to Be Presented at Cancer Therapy Meeting
Oct 21 2004
Peregrine Announces the Appointment of Prominent Scientist to Its Scientific Advisory Board
Oct 18 2004
Peregrine Pharmaceuticals Announces Successful Completion of its Antibody Humanization Project with AERES Biomedical